Lynn E. Heasley

11.1k citations
142 papers · 9.8k · 1 hit paper · h-index 53

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Protein Kinase Regulation and GTPase Signaling
    • Receptor Mechanisms and Signaling
    • Fibroblast Growth Factor Research
    • Cell death mechanisms and regulation

Papers in

    • Protein Kinase Regulation and GTPase Signaling 37
    • Fibroblast Growth Factor Research 12
    • Receptor Mechanisms and Signaling 10
    • Wnt/β-catenin signaling in development and cancer 8
    • Lung Cancer Treatments and Mutations 29

Lynn E. Heasley

139 papers receiving 9.5k citations

Lynn E. Heasley's Hit Papers

Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer 2012 · 914 citations
9140+4+9Years since publication250500750

Peers

Lynn E. Heasley
Comparison fields: 5 of 114
  • Oncology 1.5k
  • Molecular Biology 4.3k
  • Pulmonary and Respiratory Medicine 1.9k
  • Otorhinolaryngology 282
  • Developmental Neuroscience 133
Replace Alfonso Bellacosa with:
Alfonso Bellacosa United States
Hiroki Kuniyasu Japan
Sarah J. Parsons United States
Roberto D. Polakiewicz United States
Simon J. Cook United Kingdom
Naoya Fujita Japan
Andrew S. Kraft United States
Antonio Garcı́a de Herreros Spain
David S. Salomon United States
Senji Shirasawa Japan
Lynn E. Heasley relative to Alfonso Bellacosa United States Alfonso Bellacosa's profile →
Citations per field
00.5×2×2.9×
Alfonso Bellacosa · 1×
Citations per year

Countries citing papers authored by Lynn E. Heasley

Since Specialization
Citations

This map shows the geographic impact of Lynn E. Heasley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn E. Heasley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn E. Heasley more than expected).

Fields of papers citing papers by Lynn E. Heasley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn E. Heasley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn E. Heasley. The network helps show where Lynn E. Heasley may publish in the future.

Co-authors

The 25 scholars most cited alongside Lynn E. Heasley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lynn E. Heasley Line = papers co-authored together Lynn E. Heasley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer
Hit paper breakdown →
2012914
2 2000711
3 1993488
4 2018236
5 2013210
6 1989206
7 1992206
8 2008194
9 2012188
10 1995177
11 2001177
12
Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.
1999175
13 1995171
14 1997148
15 2005146
16 2017144
17 1997141
18 2014140
19 1992132
20 2010132

About Lynn E. Heasley

Lynn E. Heasley is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Otorhinolaryngology and Cellular and Molecular Neuroscience, having authored 142 papers that have together received 9.8k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (37 papers), Lung Cancer Treatments and Mutations (29 papers), Fibroblast Growth Factor Research (12 papers), Head and Neck Cancer Studies (10 papers), Receptor Mechanisms and Signaling (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Research Studies (9 papers) and Wnt/β-catenin signaling in development and cancer (8 papers). The work is most often cited by research in Oncology (1.5k citations), Molecular Biology (4.3k citations), Pulmonary and Respiratory Medicine (1.9k citations), Otorhinolaryngology (282 citations) and Developmental Neuroscience (133 citations). Lynn E. Heasley has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Gary L. Johnson, Raphael A. Nemenoff, Robert Charles Doebele, Lindsay A. Marek, Sunil Gupta, Wilbur A. Franklin, Vicki Van Putten, D. Ross Camidge, Laura Butterfield and Carol L. Sable. Their work appears in journals such as Journal of Biological Chemistry, Molecular Pharmacology, Molecular and Cellular Biology, Clinical Cancer Research and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact